Lyngstad, Gaute https://orcid.org/0000-0003-3169-3287
Skjelbred, Per https://orcid.org/0000-0002-5193-7827
Swanson, David Michael https://orcid.org/0000-0003-3174-1656
Skoglund, Lasse Ansgar https://orcid.org/0000-0003-1863-2738
Funding for this research was provided by:
Universitetet i Oslo
Oslo University Hospital, Norway
University of Oslo
Article History
Received: 28 May 2023
Accepted: 14 June 2023
First Online: 22 June 2023
Change Date: 24 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00228-024-03688-4
Declarations
:
: The trial design and performance were approved by the following Norwegian committees: Regional Committee for Ethical Medical Research (REK, South-East C S-09269c 009/5419, date 29.4.2009), the Norwegian Social Science Data Services (21617, date 26.5.2009), and the Norwegian Medicines Agency, NoMA (EudraCT 2007–001778–10, date 9.4.2009). The trial was registered June 2009 (ClinicalTrial.gov NCT00921700).
: Patients provided written informed consent prior to any screening and study-related procedures and consented to publication of the results.
: The authors declare no competing interests.